Allogene

ALLO

ALLO Allogene NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    ALLO Chart
    See on advanced chart >

    About

    Allogene Therapeutics, Inc. was incorporated on November 30, 2017 in the State of Delaware and is headquartered in South San Francisco, California. The company is a clinical stage immuno-oncology company pioneering the development and commercialization of...
    • Highlight
      A company that developing genetically engineered allogeneic T cell therapies for cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      10/11/2018
    • Established Date
      11/30/2017
    • Full-time Employees
      232
    • Address
      210 East Grand Avenue South San Francisco California 94080
    • Tel
      1-650-4572700
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-23 09:40:44